Company Number: 13805124

Analysis Date: 2025-07-29 19:28 UTC

Financial Health Assessment of Creative Spectrum Ltd

---

1. Financial Health Score: D

Explanation:
Creative Spectrum Ltd is currently showing a concerning financial health status. The company has persistent and increasing negative net current assets and shareholders' funds over the last four years, indicating ongoing financial strain. This score reflects symptoms of financial distress that, if not addressed, could jeopardize the company’s viability.

---

2. Key Vital Signs

Metric	2021 (£)	2022 (£)	2023 (£)	2024 (£)	Interpretation
Current Assets	1,005	245	245	431	Very low; minimal liquid resources
Current Liabilities	5,880	6,436	6,436	8,021	Growing liabilities due within one year
Net Current Assets	-4,875	-6,191	-6,191	-7,590	Increasing working capital deficit
Shareholders’ Funds	-4,875	-6,191	-6,191	-7,590	Negative equity; accumulated losses
Employees	1	1	1	1	Very small workforce; micro entity

Interpretation of Vital Signs:

• Negative Net Current Assets: The company’s current liabilities exceed current assets substantially, indicating an inability to cover short-term debts with liquid assets. This is a classic symptom of liquidity distress.
• Negative Shareholders’ Funds: This reflects accumulated losses and indicates that the company’s total liabilities exceed total assets. It shows an insolvency symptom on a balance sheet level.
• Minimal Current Assets: Cash or equivalent resources are very low relative to liabilities, showing an unhealthy cash flow position.
• Small Size: As a micro-entity with one employee, the company’s scale is limited, which may restrict its ability to generate sufficient cash inflows quickly.

---

3. Diagnosis

The financial statements reveal chronic financial stress manifesting as persistent negative working capital and negative net assets. The company is effectively insolvent on a balance sheet basis, given that liabilities exceed assets by £7,590 at the end of 2024, worsening year-on-year. This situation indicates ongoing funding difficulties and an inability to meet short-term obligations comfortably.

The limited current assets and negative net current assets suggest the company is experiencing symptoms of liquidity strain, which could lead to difficulties in paying suppliers, staff, or other creditors on time. The company’s reliance on a single director/shareholder who holds 75-100% control may mean financial support is dependent on this individual, but the ongoing losses indicate that operational cash generation is insufficient.

---

4. Recommendations

• Immediate Cash Flow Management:
  Conduct a rigorous cash flow forecast and prioritise payments to maintain supplier and creditor relationships. Consider negotiating extended payment terms or short-term financing options to alleviate liquidity pressure.

• Capital Injection or Financing:
  To improve the balance sheet and restore net assets to positive territory, seek additional equity investment or shareholder loans from the controlling director or external investors. This will provide a financial cushion and support operational needs.

• Cost Control and Revenue Enhancement:
  Review all operating expenses to identify cost-saving opportunities. Explore new revenue streams or increase sales efforts within the artistic creation and publishing sectors to improve income.

• Financial Monitoring:
  Implement regular financial health checks and early warning indicators to detect worsening liquidity or solvency issues promptly.

• Professional Advice:
  Engage with a financial advisor or insolvency practitioner early to explore restructuring options and to avoid escalation into formal insolvency proceedings such as administration or liquidation.

---

Medical Analogy Summary

Creative Spectrum Ltd currently exhibits symptoms of financial distress akin to a patient with a chronic illness that is worsening over time. Its "vital signs" such as negative net current assets and shareholders' funds indicate a "weakened heart" — the company’s financial core is struggling to sustain itself. Without urgent treatment via capital infusion and cash flow stabilisation, the company risks progressing to a critical state.

---